Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4169-4174

  Wang, V W ^a   Bell, D A ^a   Berkowitz, R S ^a   Mok, S C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME MICRODISSECTION; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; ALLELES; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 6; DISSECTION; FEMALE; GENE AMPLIFICATION; GENES, TUMOR SUPPRESSOR; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 0035872483     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality
2. Human tumor suppressor genes
3. Loss of constitutional heterozygosity in human cancer
4. Human epithelial ovarian cancer allelotype
5. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer
6. Whole genome amplification from a single cell: Implications for genetic analysis
7. Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer
8. Multiple PCR analyses on trace amounts of DNA extracted from fresh and paraffin wax embedded tissues after random hexamer primer PCR amplification
9. Multiple mutation analyses in single tumor cells with improved whole genome amplification
10. Laser capture microdissection
11. Practical histological microdissection for PCR analysis
12. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
13. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology
14. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas
15. Loss of heterozygosity on chromosomal segments 3p, 6q, and 11p in human ovarian carcinoma
16. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas
17. Molecular genetic changes associated with ovarian cancer
18. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21
19. Allelic loss on chromosome arm 8p: Analysis of sporadic epithelial ovarian tumors
20. Genotypic analysis of multiple loci in somatic cells by whole genome amplification
21. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labelled microsatellite analysis
22. Preimplantation single cell analyses of dystrophin gene deletions using whole genome amplification
23. Preimplantation single-cell analysis of multiple genetic loci by whole-genome amplification
24. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood
25. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia
26. Allelotype of human ovarian cancer
27. Allelic loss in ovarian cancer
28. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22
29. Genetic analysis of synchronous mucinous tumors of the ovary and appendix
30. Molecular genetic changes in human epithelial ovarian malignancies
31. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification
32. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas
33. Stable amino-acid sequence of the mannose-6-phosphate/insulin-like growth-factor-II receptor in ovarian carcinomas with loss of heterozygosity and in breast-cancer cell lines
34. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer